好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Acute Ischemic Stroke with Anterior Circulation Large Vessel Occlusion and Tandem Carotid Lesions
Cerebrovascular Disease and Interventional Neurology
P6 - Poster Session 6 (5:00 PM-6:00 PM)
5-010

Perform a retrospective review of large vessel occlusion (LVO) in acute ischemic stroke (AIS) cases with tandem carotid lesions at a single center academic comprehensive stroke.

Tandem cervical carotid lesions in combination with LVO represent a unique challenge in AIS management with mechanical thrombectomy (MT) and the optimal treatment approach is unclear.

Among 220 LVO AIS patients who presented within 24 hours from last known well time (LKN) to our institution from May 2023 to June 30, 2024, we identified 36 (16.4%) patients with LVO and tandem carotid lesion. Data was collected on demographics, LKN, neuroimaging results, National Institute of Health Stroke Scale (NIHSS), thrombolysis time, and MT results.

Among 36 patients with LVO and tandem lesions, the mean age was 69.7 years (range, 40.0 to 95.0) and 15 (41.7%) were female. The mean NIHSS was 13.8 (range 3 to 23). The mean time from LKN to CTA was 7.6 hours (range, 0.4 to 20.6). The location of LVO was as follows: 23 (64.9%) M1, 9 (25.0%) M2, and 4 (11.1%) ICAT.  Among the tandem lesions, 30 (83.3%) were carotid occlusions and 6 (16.6%) were carotid stenoses. Fourteen (38.9%) received thrombolysis at a mean time from LKN 2.0 hours (range, 1.0 to 3.1).  Among 14 (38.9%) patients who underwent MT, 11 (78.6%) had successful recanalization. Among 22 patients excluded MT, proximal carotid occlusion was documented as the reason in 12 (54.5%). Patients with tandem carotid stenosis did not significantly differ from patients with tandem carotid occlusion in terms of age, sex, NIHSS, and time from LKN, but did have a higher rate of MT (83.3% vs 30.0%, p 0.014).

In LVO and tandem lesions, proximal carotid occlusion underwent MT at a lower rate than carotid stenosis. Further study warranted to optimize treatment in LVO patients with tandem carotid lesions.

Authors/Disclosures
Randheer Yadav, NP
PRESENTER
Mr. Yadav has nothing to disclose.
Kendall Bader, NP Mrs. Bader has nothing to disclose.
Shahid Nimjee, MD, PhD (The Ohio State University Wexner Medical Center) Dr. Nimjee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Silvercreek. Dr. Nimjee has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Dr. Nimjee has stock in Basking Biosciences. The institution of Dr. Nimjee has received research support from National Institutes of Health.
Ciaran Powers, MD, PhD Dr. Powers has nothing to disclose.
Patrick P. Youssef, MD Dr. Youssef has nothing to disclose.
Cassandra Forrest (Wexner medical Center) Cassandra Forrest has nothing to disclose.
Vivien H. Lee, MD, FAAN (OSU Comprehensive Neurovascular Center) Dr. Lee has nothing to disclose.